Form 4: STERIS Executive Kenneth Kohler Reports Share Withholding

STERIS SVP Kenneth E. Kohler reported the withholding of 184 shares to cover tax obligations following the vesting of restricted stock.

Summary

• Kenneth E. Kohler, SVP & GM of AST at STERIS plc, reported a transaction involving the withholding of 184 ordinary shares.
• The transaction occurred on June 3, 2026, at a price of $210.19 per share.
• The withholding was executed to satisfy tax obligations related to the vesting of 630 restricted shares.
• Following this transaction, the reporting person maintains a beneficial ownership of 11,482 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event with no impact on the company's fundamental outlook.

Positives

• The transaction reflects the vesting of equity-based compensation, aligning executive interests with long-term shareholder value.

Negatives

• None; this is a routine administrative transaction related to tax withholding upon the vesting of equity awards.

Risks

• None; this filing pertains to standard executive compensation tax compliance.

Future Outlook

The filing does not provide forward-looking financial guidance, but outlines a schedule for the future vesting of restricted shares through June 2029.

Industry Context

StockSavvy.ai notes that this is a standard regulatory disclosure for executive compensation and does not signal a change in corporate strategy or market outlook.

Comparison to Industry Standards

• The practice of withholding shares to cover tax liabilities upon vesting is a standard industry practice for publicly traded companies in the medical device and healthcare sector.

Stakeholder Impact

• No material impact on shareholders, employees, or creditors.

Next Steps

• Future vesting of restricted shares scheduled for June 2026, 2027, 2028, and 2029.

Key Dates

Keywords

STERIS, STE, Form 4, Insider Trading, Equity Vesting, Tax Withholding, Corporate Governance